New guidelines recommend plasma exchange for patients with severe relapses of multiple sclerosis (MS) and for those with nerve disorders such as neuropathy.

A "master switch" protein in white blood cells has been found to influence whether the cells promote or hinder inflammation, according to a new study.

The genetic mechanism that destroys brain cells responsible for Alzheimer's disease is also the cause of early development of Alzheimer's disease in people with Down Syndrome.

A study by the Institute of Aging Research suggests that treating the symptoms and stress associated with advanced dementia may be more efficient than aggressive treatment for the illness.

In multiple sclerosis (MS), white blood cells known as leukocytes enter the central nervous system (CNS) with help from a family of molecules (MMPs) and then damage the protective coating called myelin around nerves.

Past studies have established links between anti-epileptic drugs and bone density loss . Now, new research indicates that specific anti-epileptic drugs correspond to an increased risk of bone fractures in people 50 years of age and older.

Mindful meditation -- a combination of gentle yoga maneuvers and meditation -- doesn't appear to help those with the chronic pain condition known as fibromyalgia.

Oral bisphosphonates, a treatment for bone disease, may double the risk of developing esophageal cancer (cancer of the gullet), according to a new study from the University of Oxford.

Findings from a new study indicate a host of new clinical, functional, and neuroimaging tests are able to track the progression of Huntington's disease (HD) before outward symptoms begin to appear.

A naturally occurring compound found in strawberries and other produce has been shown to slow motor problems and death associated with three models of Huntington's disease.